{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T12:08:50Z","timestamp":1768738130294,"version":"3.49.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,2,2]],"date-time":"2012-02-02T00:00:00Z","timestamp":1328140800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Cardiol"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1007\/s00246-012-0162-6","type":"journal-article","created":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T10:37:08Z","timestamp":1328092628000},"page":"394-401","source":"Crossref","is-referenced-by-count":32,"title":["Attention-Deficit\/Hyperactivity Disorder, Stimulant Therapy, and the Patient with Congenital Heart Disease: Evidence and Reason"],"prefix":"10.1007","volume":"33","author":[{"given":"Anjan S.","family":"Batra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark E.","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Silka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,2,2]]},"reference":[{"key":"162_CR1","unstructured":"Alexander M et al (2011) PACES survey. Presented at the HRS annual meeting"},{"key":"162_CR2","doi-asserted-by":"crossref","unstructured":"American Academy of Pediatrics, Steering Committee on Quality Improvement and Management (2004) Classifying recommendations for clinical practice guidelines. Pediatrics 114:874\u2013877","DOI":"10.1542\/peds.2004-1260"},{"key":"162_CR3","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1001\/archpedi.156.3.217","volume":"156","author":"WJ Barbaresi","year":"2002","unstructured":"Barbaresi WJ, Katusic SK, Colligan RC, Pankratz VS, Weaver AL, Weber KJ, Mrazek DA, Jacobsen SJ (2002) How common is attention-deficit\/hyperactivity disorder? Incidence in a population-based birth cohort in Rochester, Minnesota. Arch Pediatr Adolesc Med 156:217\u2013224","journal-title":"Arch Pediatr Adolesc Med"},{"key":"162_CR4","unstructured":"Berger S, Campbell R, Drezner J (2009) PACES survey. http:\/\/www.pediatricepsociety.org\/links\/ . Accessed Sep 2011"},{"key":"162_CR5","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1542\/peds.110.2.258","volume":"110","author":"J Biederman","year":"2002","unstructured":"Biederman J, Lopez FA, Boellner SW, Chandler MC (2002) A randomized, double-blind, placebo-controlled, parallel-group study of SLI381 (Adderall XR) in children with attention-deficit\/hyperactivity disorder. Pediatrics 110:258\u2013266","journal-title":"Pediatrics"},{"key":"162_CR6","doi-asserted-by":"crossref","first-page":"E43","DOI":"10.1542\/peds.107.3.e43","volume":"107","author":"RT Brown","year":"2001","unstructured":"Brown RT, Freeman WS, Perrin JM, Stein MT, Amler RW, Feldman HM, Pierce K, Wolraich ML (2001) Prevalence and assessment of attention-deficit\/hyperactivity disorder in primary care settings. Pediatrics 107:E43","journal-title":"Pediatrics"},{"key":"162_CR7","doi-asserted-by":"crossref","first-page":"e828","DOI":"10.1542\/peds.2008-0276","volume":"122","author":"J Conway","year":"2008","unstructured":"Conway J, Wong KK, O\u2019Connell C, Warren AE (2008) Cardiovascular risk screening before starting stimulant medications and prescribing practices of Canadian physicians: impact of the Health Canada Advisory. Pediatrics 122:e828\u2013e834","journal-title":"Pediatrics"},{"key":"162_CR8","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/00004583-200105000-00011","volume":"40","author":"RL Findling","year":"2001","unstructured":"Findling RL, Short EJ, Manos MJ (2001) Short-term cardiovascular effects of methylphenidate and Adderall. J Am Acad Child Adolesc Psychiatry 40:525\u2013529","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"162_CR9","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jpeds.2005.03.014","volume":"147","author":"RL Findling","year":"2005","unstructured":"Findling RL, Biederman J, Wilens TE, Spencer TJ, McGough JJ, Lopez FA, Tulloch SJ (2005) Short- and long-term cardiovascular effects of mixed amphetamine salts extended release in children. J Pediatr 147:348\u2013354","journal-title":"J Pediatr"},{"key":"162_CR10","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.4088\/JCP.v64n1004","volume":"64","author":"D Gothelf","year":"2003","unstructured":"Gothelf D, Gruber R, Presburger G, Dotan I, Brand-Gothelf A, Burg M, Inbar D, Steinberg T, Frisch A, Apter A, Weizman A (2003) Methylphenidate treatment for attention-deficit\/hyperactivity disorder in children and adolescents with velocardiofacial syndrome: an open-label study. J Clin Psychiatry 64:1163\u20131169","journal-title":"J Clin Psychiatry"},{"key":"162_CR11","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1176\/appi.ajp.2009.09040472","volume":"166","author":"MS Gould","year":"2009","unstructured":"Gould MS, Walsh BT, Munfakh JL, Kleinman M, Duan N, Olfson M, Greenhill L, Cooper T (2009) Sudden death and use of stimulant medications in youths. Am J Psychiatry 166:992\u20131001","journal-title":"Am J Psychiatry"},{"key":"162_CR12","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1161\/01.CIR.99.7.979","volume":"99","author":"H Gutgesell","year":"1999","unstructured":"Gutgesell H, Atkins D, Barst R, Buck M, Franklin W, Humes R, Ringel R, Shaddy R, Taubert KA (1999) AHA scientific statement: cardiovascular monitoring of children and adolescents receiving psychotropic drugs. Circulation 99:979\u2013982","journal-title":"Circulation"},{"key":"162_CR13","unstructured":"Health Canada (2006) Search page. www.hc-sc.gc.ca\/dhp-mps\/medeff\/advisories-avis\/prof\/_2006\/adhd-tdah_medic_hpc-cps-eng.php . Accessed Sep 2011"},{"key":"162_CR14","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ahj.2003.05.003","volume":"147","author":"JI Hoffman","year":"2004","unstructured":"Hoffman JI, Kaplan S, Liberthson RR (2004) Prevalence of congenital heart disease. Am Heart J 147:425\u2013439","journal-title":"Am Heart J"},{"key":"162_CR15","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.jtcvs.2004.08.013","volume":"129","author":"PM Kirshbom","year":"2005","unstructured":"Kirshbom PM, Flynn TB, Clancy RR, Ittenbach RF, Hartman DM, Paridon SM, Wernovsky G, Spray TL, Gaynor JW (2005) Late neurodevelopmental outcomes after repair of total anomalous pulmonary venous connections. J Thorac Cardiovasc Surg 129:1091\u20131096","journal-title":"J Thorac Cardiovasc Surg"},{"key":"162_CR16","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1542\/peds.105.5.1082","volume":"105","author":"WT Mahle","year":"2000","unstructured":"Mahle WT, Clancy RR, Moss EM, Gerdes M, Jobes DR, Wernovsky G (2000) Neurodevelopmental outcome and lifestyle assessment in school-aged and adolescent children with hypoplastic left heart syndrome. Pediatrics 105:1082\u20131089","journal-title":"Pediatrics"},{"key":"162_CR17","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.2165\/11317630-000000000-00000","volume":"32","author":"S McCarthy","year":"2009","unstructured":"McCarthy S, Cranswick N, Potts L, Taylor E, Wong IC (2009) Mortality associated with attention-deficit hyperactivity disorder (ADHD) drug treatment: a retrospective cohort study of children, adolescents, and young adults using the general practice research database. Drug Saf 32:1089\u20131096","journal-title":"Drug Saf"},{"key":"162_CR18","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1542\/peds.2008-1573","volume":"122","author":"JM Perrin","year":"2008","unstructured":"Perrin JM, Friedman RA, Knilans TK (2008) Cardiovascular monitoring and stimulant drugs for attention-deficit\/hyperactivity disorder. Pediatrics 122:451\u2013453","journal-title":"Pediatrics"},{"key":"162_CR19","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1542\/peds.2010-3371","volume":"127","author":"H Schelleman","year":"2011","unstructured":"Schelleman H, Bilker WB, Strom BL, Kimmel SE, Newcomb C, Guevara JP, Daniel GW, Cziraky MJ, Hennessy S (2011) Cardiovascular events and death in children exposed and unexposed to ADHD agents. Pediatrics 127:1102\u20131110","journal-title":"Pediatrics"},{"key":"162_CR20","doi-asserted-by":"crossref","first-page":"e759","DOI":"10.1542\/peds.2007-1066","volume":"121","author":"AJ Shillingford","year":"2008","unstructured":"Shillingford AJ, Glanzman MM, Ittenbach RF, Clancy RR, Gaynor JW, Wernovsky G (2008) Inattention, hyperactivity, and school performance in a population of school-age children with complex congenital heart disease. Pediatrics 121:e759\u2013e767","journal-title":"Pediatrics"},{"key":"162_CR21","unstructured":"U.S. Food and Drug Administation (2007) FDA directs ADHD drug manufacturers to notify patients about cardiovascular adverse events and psychiatric adverse events. http:\/\/www.fda.gov\/bbs\/topics\/news\/2007\/new01568.html . Accessed Sep 2011"},{"key":"162_CR22","unstructured":"U.S. Food and Drug Administration (2005) Detailed view: safety labeling changes approved by FDA Center for Drug Evaluation and Research (CDER). http:\/\/www.fda.gov\/medwatch\/safety\/2005\/aug05.htm . Accessed Sep 2011"},{"key":"162_CR23","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1161\/CIRCULATIONAHA.107.189473","volume":"117","author":"VL Vetter","year":"2008","unstructured":"Vetter VL, Elia J, Erickson C, Berger S, Blum N, Uzark K, Webb CL (2008) Cardiovascular monitoring of children and adolescents with heart disease receiving medications for attention deficit\/hyperactivity disorder (corrected): a scientific statement from the American heart association council on cardiovascular disease in the young congenital cardiac defects committee and the council on cardiovascular nursing. Circulation 117:2407\u20132423","journal-title":"Circulation"},{"key":"162_CR24","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0828-282X(09)70157-6","volume":"25","author":"AE Warren","year":"2009","unstructured":"Warren AE, Hamilton RM, B\u00e9langer SA, Gray C, Gow RM, Sanatani S, C\u00f4t\u00e9 JM, Lougheed J, LeBlanc J, Martin S, Miles B, Mitchell C, Gorman DA, Weiss M, Schachar R (2009) Cardiac risk assessment before the use of stimulant medications in children and youth: a joint position statement by the Canadian paediatric society, the Canadian cardiovascular society, and the Canadian academy of child and adolescent psychiatry. Can J Cardiol 25:625\u2013630","journal-title":"Can J Cardiol"},{"key":"162_CR25","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.spen.2010.10.005","volume":"17","author":"SB Wigal","year":"2010","unstructured":"Wigal SB, Chae S, Patel A, Steinberg-Epstein R (2010) Advances in the treatment of attention-deficit\/hyperactivity disorder: a guide for pediatric neurologists. Semin Pediatr Neurol 17:230\u2013236","journal-title":"Semin Pediatr Neurol"},{"key":"162_CR26","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1542\/peds.2006-0942","volume":"118","author":"TE Wilens","year":"2006","unstructured":"Wilens TE, Prince JB, Spencer TJ, Biederman J (2006) Stimulants and sudden death: what is a physician to do? Pediatrics 118:1215\u20131219","journal-title":"Pediatrics"},{"key":"162_CR27","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1542\/peds.108.4.883","volume":"108","author":"ML Wolraich","year":"2001","unstructured":"Wolraich ML, Greenhill LL, Pelham W, Swanson J, Wilens T, Palumbo D, Atkins M, McBurnett K, Bukstein O, August G (2001) Randomized, controlled trial of OROS methylphenidate once a day in children with attention-deficit\/hyperactivity disorder. Pediatrics 108:883\u2013892","journal-title":"Pediatrics"}],"container-title":["Pediatric Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-012-0162-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00246-012-0162-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-012-0162-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,22]],"date-time":"2019-06-22T23:57:10Z","timestamp":1561247830000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00246-012-0162-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,2]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["162"],"URL":"https:\/\/doi.org\/10.1007\/s00246-012-0162-6","relation":{},"ISSN":["0172-0643","1432-1971"],"issn-type":[{"value":"0172-0643","type":"print"},{"value":"1432-1971","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,2]]}}}